News

Prime Medicine Announces Pricing of Public Offering
Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time ...
2 Reasons to Like PRIM (and 1 Not So Much)
Stocks We Like Even More Than Primoris When Trump unveiled his aggressive tariff plan in April 2024, markets tanked as ...